4 hours ago ... Recently, the glucago*-like peptide-1 receptor (GLP-1R) has become a primary target in diabetes and obesity treatment because of its role inĀ ...
As said here by https://www.news-medical.net/whitepaper/20260107/Are-peptide-drugs-the-only-answer-to-the-hundred-billion-level-weight-loss-market.aspx